nach oben

Erschienen in:

22.11.2018

Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients

verfasst von: Evan Tang, Oladapo Ekundayo, John Devin Peipert, Nathaniel Edwards, Aarushi Bansal, Candice Richardson, Susan J. Bartlett, Doris Howell, Madeline Li, David Cella, Marta Novak, Istvan Mucsi

Erschienen in: Quality of Life Research | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

The Patient-Reported Outcomes Measurement Information System (PROMIS) aims to address the lack of generalizable and universal measure of patient-reported outcomes to assess health-related quality of life. It has not been validated for patients with chronic kidney disease. We aim to validate the PROMIS-57 and PROMIS-29 questionnaires among kidney transplant recipients.

Methods

A cross-sectional sample of stable kidney transplant recipients was recruited. Each participant completed PROMIS-57, a 57-question instrument covering seven domains—physical function, anxiety, depression, fatigue, pain, sleep disturbance, and social functioning—alongside validated legacy questionnaires [Patient Health Questionnaire (PHQ9), General Anxiety Disorder (GAD7), Edmonton Symptom Assessment Scale revised (ESASr), and Kidney Disease Quality of Life (KDQoL-36)]. PROMIS-29, a 29-question instrument, is nested within PROMIS-57 and measures the same domains. Structural validity of PROMIS was assessed with confirmatory factor analysis, reported using the Comparative Fit Index (CFI). Construct validity was assessed with known-groups comparisons. Internal consistency was evaluated with Cronbach’s α and convergent validity was assessed with Spearman’s Rho. Test–retest reliability was assessed through the intraclass correlation coefficient (ICC).

Results

Mean (± SD) age of the 177 participants was 50 (± 17), 57% were male and 55% Caucasian. Internal consistency of each domain was high (Cronbach’s α > 0.88). Confirmatory factor analysis showed good structural validity for most domains (CFI > 0.95, RMSEA < 0.05). Test–retest reliability indicated good agreement (ICC > 0.6). Known-groups comparisons by clinical and socio-demographic differences were found as hypothesized.

Conclusions

Our results provide evidence that PROMIS-57 and PROMIS-29 are highly reliable and valid instruments among kidney transplant recipients. We propose it as a valuable tool to assess important domains of the illness experience.

Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047–1053. https://doi.org/10.2337/diacare.27.5.1047.PubMedCrossRef

Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., et al. (2016). Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation, 134(6), 441–450. https://doi.org/10.1161/circulationaha.115.018912.PubMedPubMedCentralCrossRef

Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2095–2128. https://doi.org/10.1016/s0140-6736(12)61728-0.CrossRef

Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K. U., et al. (2007). Chronic kidney disease as a global public health problem: Approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney International, 72(3), 247–259. https://doi.org/10.1038/sj.ki.5002343.PubMedCrossRef

Akbari, A., Clase, C. M., Acott, P., Battistella, M., Bello, A., Feltmate, P., et al. (2015). Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management. American Journal of Kidney Diseases, 65(2), 177–205. https://doi.org/10.1053/j.ajkd.2014.10.013.PubMedCrossRef

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012. (2013). Clinical practice guideline for the evaluation and management of chronic kidney disease. Official Journal of the International Society of Nephrology: Kidney International Supplements, 3, 1–150.

Cetingok, M., Hathaway, D. K., & Winsett, R. R. (2005). Differences in quality of life before transplantation among transplant recipients with respect to selected socioeconomic variables. Progress in Transplantation, 15(4), 338–344.PubMedCrossRef

Franke, G. H., Reimer, J., Kohnle, M., Luetkes, P., Maehner, N., & Heemann, U. (1999). Quality of life in end-stage renal disease patients after successful kidney transplantation: Development of the ESRD symptom checklist—transplantation module. Nephron, 83(1), 31–39. https://doi.org/10.1159/000045470.PubMedCrossRef

Molnar-Varga, M., Molnar, M. Z., Szeifert, L., Kovacs, A. Z., Kelemen, A., Becze, A., et al. (2011). Health-related quality of life and clinical outcomes in kidney transplant recipients. American Journal of Kidney Diseases, 58(3), 444–452. https://doi.org/10.1053/j.ajkd.2011.03.028.PubMedCrossRef

10.

Muehrer, R. J., & Becker, B. N. (2005). Psychosocial factors in patients with chronic kidney disease: Life After Transplantation: New Transitions in Quality of Life and Psychological Distress. Seminars in Dialysis, 18(2), 124–131. https://doi.org/10.1111/j.1525-139X.2005.18214.x.PubMedCrossRef

11.

Barnieh, L., Yilmaz, S., McLaughlin, K., Hemmelgarn, B. R., Klarenbach, S., Manns, B. J., et al. (2014). The cost of kidney transplant over time. Progress in Transplantation, 24(3), 257–262. https://doi.org/10.7182/pit2014710.PubMedCrossRef

12.

Klarenbach, S. W., Tonelli, M., Chui, B., & Manns, B. J. (2014). Economic evaluation of dialysis therapies. Nature Reviews Nephrology, 10(11), 644–652. https://doi.org/10.1038/nrneph.2014.145.PubMedCrossRef

13.

Wang, V., Vilme, H., Maciejewski, M. L., & Boulware, L. E. (2016). The economic burden of chronic kidney disease and end-stage renal disease. Seminars in Nephrology, 36(4), 319–330. https://doi.org/10.1016/j.semnephrol.2016.05.008.PubMedCrossRef

14.

Overbeck, I., Bartels, M., Decker, O., Harms, J., Hauss, J., & Fangmann, J. (2005). Changes in quality of life after renal transplantation. Transplantation Proceedings, 37(3), 1618–1621. https://doi.org/10.1016/j.transproceed.2004.09.019.PubMedCrossRef

15.

Weldring, T., & Smith, S. M. S. (2013). Patient-reported outcomes (PROS) and patient-reported outcome measures (PROMs). Health Services Insights, 6, 61–68. https://doi.org/10.4137/HSI.S11093.PubMedPubMedCentralCrossRef

16.

Deshpande, P. R., Rajan, S., Sudeepthi, B. L., & Abdul Nazir, C. P. (2011). Patient-reported outcomes: A new era in clinical research. Perspectives in Clinical Research, 2(4), 137–144. https://doi.org/10.4103/2229-3485.86879.PubMedPubMedCentralCrossRef

17.

Hvitfeldt, H., Carli, C., Nelson, E. C., Mortenson, D. M., Ruppert, B. A., & Lindblad, S. (2009). Feed forward systems for patient participation and provider support: Adoption results from the original US context to Sweden and beyond. Quality Management in Health Care, 18(4), 247–256. https://doi.org/10.1097/QMH.0b013e3181bee32e.PubMedCrossRef

18.

Tang, E., Bansal, A., Novak, M., & Mucsi, I. (2018). Patient-reported outcomes in patients with chronic kidney disease and kidney transplant—part 1. (Review). Frontiers in Medicine. https://doi.org/10.3389/fmed.2017.00254.PubMedPubMedCentralCrossRef

19.

Wysham, N. G., Wolf, S. P., Samsa, G., Abernethy, A. P., & LeBlanc, T. W. (2017). Integration of electronic patient-reported outcomes into routine cancer care: An analysis of factors affecting data completeness. JCO Clinical Cancer Informatics. https://doi.org/10.1200/CCI.16.00043.PubMedCrossRef

20.

Basch, E., Bennett, A., & Pietanza, M. C. (2011). Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. JNCI: Journal of the National Cancer Institute, 103(24), 1808–1810. https://doi.org/10.1093/jnci/djr493.PubMedCrossRef

21.

Matsen, F. A., Russ, S. M., Vu, P. T., Hsu, J. E., Lucas, R. M., & Comstock, B. A. (2016). What factors are predictive of patient-reported outcomes? A prospective study of 337 shoulder arthroplasties. Clinical Orthopaedics and Related Research, 474(11), 2496–2510. https://doi.org/10.1007/s11999-016-4990-1.PubMedPubMedCentralCrossRef

22.

Basch, E., Deal, A. M., Dueck, A. C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318(2), 197–198. https://doi.org/10.1001/jama.2017.7156.PubMedPubMedCentralCrossRef

23.

Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., et al. (2007). The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3–Ss11. https://doi.org/10.1097/01.mlr.0000258615.42478.55.PubMedPubMedCentralCrossRef

24.

Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194. https://doi.org/10.1016/j.jclinepi.2010.04.011.PubMedPubMedCentralCrossRef

25.

Riley, W. T., Rothrock, N., Bruce, B., Christodolou, C., Cook, K., Hahn, E. A., et al. (2010). Patient-Reported Outcomes Measurement Information System (PROMIS) domain names and definitions revisions: Further evaluation of content validity in IRT-derived item banks. Quality of Life Research, 19(9), 1311–1321. https://doi.org/10.1007/s11136-010-9694-5.PubMedPubMedCentralCrossRef

26.

Alphen, A., Halfens, R., Hasman, A., & Imbos, T. (1994). Likert or Rasch? Nothing is more applicable than good theory. Journal of Advanced Nursing, 20(1), 196–201. https://doi.org/10.1046/j.1365-2648.1994.20010196.x.PubMedCrossRef

27.

Thomas, M. L. (2011). The value of item response theory in clinical assessment: A review. Assessment, 18(3), 291–307. https://doi.org/10.1177/1073191110374797.PubMedCrossRef

28.

Reeve, B. B., Hays, R. D., Bjorner, J. B., Cook, K. F., Crane, P. K., Teresi, J. A., et al. (2007). Psychometric evaluation and calibration of health-related quality of life item banks: Plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Medical Care, 45(5 Suppl 1), S22–S31. https://doi.org/10.1097/01.mlr.0000250483.85507.04.PubMedCrossRef

29.

Carle, A. C., Cella, D., Cai, L., Choi, S. W., Crane, P. K., Curtis, S. M., et al. (2011). Advancing PROMIS’s methodology: Results of the third Patient-Reported Outcomes Measurement Information System (PROMIS((R))) psychometric summit. Expert Review of Pharmacoeconomics & Outcomes Research, 11(6), 677–684. https://doi.org/10.1586/erp.11.74.CrossRef

30.

Gershon, R. C., Rothrock, N., Hanrahan, R., Bass, M., & Cella, D. (2010). The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. Journal of Applied Measurement, 11(3), 304–314.PubMedPubMedCentral

31.

Jensen, R. E., Potosky, A. L., Reeve, B. B., Hahn, E., Cella, D., Fries, J., et al. (2015). Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Quality of Life Research, 24(10), 2333–2344. https://doi.org/10.1007/s11136-015-0992-9.PubMedPubMedCentralCrossRef

32.

Buysse, D. J., Yu, L., Moul, D. E., Germain, A., Stover, A., Dodds, N. E., et al. (2010). Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep, 33(6), 781–792.PubMedPubMedCentralCrossRef

33.

Schalet, B. D., Pilkonis, P. A., Yu, L., Dodds, N., Johnston, K. L., Yount, S., et al. (2016). Clinical validity of PROMIS(®) depression, anxiety, and anger across diverse clinical samples. Journal of Clinical Epidemiology, 73, 119–127. https://doi.org/10.1016/j.jclinepi.2015.08.036.PubMedPubMedCentralCrossRef

34.

Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., & Cella, D. (2011). Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): Depression, anxiety, and anger. Assessment, 18(3), 263–283. https://doi.org/10.1177/1073191111411667.PubMedPubMedCentralCrossRef

35.

Cella, D., Lai, J.-S., Jensen, S. E., Christodoulou, C., Junghaenel, D. U., Reeve, B. B., et al. (2016). Clinical validity of the PROMIS(®) fatigue item bank across diverse clinical samples. Journal of Clinical Epidemiology, 73, 128–134. https://doi.org/10.1016/j.jclinepi.2015.08.037.PubMedPubMedCentralCrossRef

36.

Askew, R. L., Cook, K. F., Revicki, D. A., Cella, D., & Amtmann, D. (2016). Evidence from diverse clinical populations supported clinical validity of PROMIS pain interference and pain behavior. Journal of Clinical Epidemiology. 73, 103–111. https://doi.org/10.1016/j.jclinepi.2015.08.035.PubMedPubMedCentralCrossRef

37.

Hahn, E. A., DeVellis, R. F., Bode, R. K., Garcia, S. F., Castel, L. D., Eisen, S. V., et al. (2010). Measuring social health in the Patient-Reported Outcomes Measurement Information System (PROMIS): Item bank development and testing. Quality of Life Research, 19(7), 1035–1044.PubMedPubMedCentralCrossRef

38.

Fries, J. F., Witter, J., Rose, M., Cella, D., Khanna, D., & Morgan-DeWitt, E. (2014). Item response theory, computerized adaptive testing, and PROMIS: Assessment of physical function. Journal of Rheumatology, 41(1), 153–158. https://doi.org/10.3899/jrheum.130813.PubMedCrossRef

39.

Revicki, D. A., Chen, W. H., Harnam, N., Cook, K. F., Amtmann, D., Callahan, L. F., et al. (2009). Development and psychometric analysis of the PROMIS pain behavior item bank. Pain, 146(1–2), 158–169. https://doi.org/10.1016/j.pain.2009.07.029.PubMedPubMedCentralCrossRef

40.

Magasi, S., Ryan, G., Revicki, D., Lenderking, W., Hays, R. D., Brod, M., et al. (2012). Content validity of patient-reported outcome measures: Perspectives from a PROMIS meeting. Quality of Life Research, 21(5), 739–746. https://doi.org/10.1007/s11136-011-9990-8.PubMedCrossRef

41.

Liu, H., Cella, D., Gershon, R., Shen, J., Morales, L. S., Riley, W., et al. (2010). Representativeness of the PROMIS internet panel. Journal of Clinical Epidemiology, 63(11), 1169–1178. https://doi.org/10.1016/j.jclinepi.2009.11.021.PubMedPubMedCentralCrossRef

42.

Barotfi, S., Molnar, M. Z., Almasi, C., Kovacs, A. Z., Remport, A., Szeifert, L., et al. (2006). Validation of the kidney disease quality of life-short form questionnaire in kidney transplant patients. Journal of Psychosomatic Research, 60(5), 495–504. https://doi.org/10.1016/j.jpsychores.2005.09.009.PubMedCrossRef

43.

Fiebiger, W., Mitterbauer, C., & Oberbauer, R. (2004). Health-related quality of life outcomes after kidney transplantation. Health and Quality of Life Outcomes, 2, 2–2. https://doi.org/10.1186/1477-7525-2-2.PubMedPubMedCentralCrossRef

44.

Ricardo, A. C., Hacker, E., Lora, C. M., Ackerson, L., DeSalvo, K. B., Go, A., et al. (2013). Validation of the kidney disease quality of life short form 36 (KDQOL-36™) US Spanish and English versions in a cohort of hispanics with chronic kidney disease. Ethnicity and Disease, 23(2), 202–209.PubMed

45.

Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the kidney disease quality of life (KDQOL) instrument. Quality of Life Research, 3(5), 329–338.PubMedCrossRef

46.

Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in nine countries. Journal of Clinical Epidemiology, 51(11), 1171–1178. https://doi.org/10.1016/S0895-4356(98)00109-7.PubMedCrossRef

47.

Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The RAND 36-item health survey 1.0. Health Economics, 2(3), 217–227.PubMedCrossRef

48.

Davison, S. N., Jhangri, G. S., & Johnson, J. A. (2006). Cross-sectional validity of a modified Edmonton Symptom Assessment System in dialysis patients: A simple assessment of symptom burden. Kidney International, 69(9), 1621–1625. https://doi.org/10.1038/sj.ki.5000184.PubMedCrossRef

49.

Watanabe, S. M., Nekolaichuk, C. L., & Beaumont, C. (2012). The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: Development and refinement. Psycho-Oncology, 21(9), 977–985. https://doi.org/10.1002/pon.1996.PubMedCrossRef

50.

Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton symptom assessment system (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 6–9.PubMedCrossRef

51.

Pokarowski, M., Liao, S. D.,A. A.,M. K.,O. E., B., et al. (2018). Validation of Edmonton Symptom Assessment System in kidney transplant recipients (KTR). American Transplant Congress, June 2–6, 2018; Seattle, Washington.

52.

Davison, S. N., Jhangri, G. S., & Johnson, J. A. (2006). Longitudinal validation of a modified Edmonton Symptom Assessment System (ESAS) in haemodialysis patients. Nephrology, Dialysis, Transplantation, 21(11), 3189–3195. https://doi.org/10.1093/ndt/gfl380.PubMedCrossRef

53.

Pokarowski, M., Albdalla, D. S., Khalid, A., Ekundayo, M., Liao, O., Edwards, Y., & Mucsi, N. I. (2017). Validation of Edmonton symptom assessment survey in kidney transplant recipients (KTR). American Journal of Transplantation. 17(suppl 3), 698

54.

Davison, S. N., Levin, A., Moss, A. H., Jha, V., Brown, E. A., Brennan, F., et al. (2015). Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: Developing a roadmap to improving quality care. Kidney International, 88(3), 447–459. https://doi.org/10.1038/ki.2015.110.PubMedCrossRef

55.

Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. [Research Support, Non-U.S. Gov’t. validation studies. Journal of General Internal Medicine, 16(9), 606–613.PubMedPubMedCentralCrossRef

56.

Kroenke, K., Spitzer, R. L., Williams, J. W., Monahan, P. O., & Löwe, B. (2007). Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Annals of Internal Medicine, 146(5), 317–325. https://doi.org/10.7326/0003-4819-146-5-200703060-00004.PubMedCrossRef

57.

Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092.PubMedCrossRef

58.

Watnick, S., Wang, P. L., Demadura, T., & Ganzini, L. (2005). Validation of 2 depression screening tools in dialysis patients. American Journal of Kidney Diseases, 46(5), 919–924. https://doi.org/10.1053/j.ajkd.2005.08.006.PubMedCrossRef

59.

Chilcot, J., Hudson, J. L., Moss-Morris, R., Carroll, A., Game, D., Simpson, A., et al. (2018). Screening for psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): Initial validation of structural validity in dialysis patients. General Hospital Psychiatry, 50, 15–19. https://doi.org/10.1016/j.genhosppsych.2017.09.007.PubMedCrossRef

60.

Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., et al. (2014). Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. Journal of Clinical Oncology, 32(15), 1605–1619. https://doi.org/10.1200/JCO.2013.52.4611.PubMedPubMedCentralCrossRef

61.

Howell, D., Keshavarz, H., Esplen, M. J., Hack, T., Hamel, M., Howes, J., et al. (2010). Pan-Canadian practice guideline: Screening, assessment and management of psychosocial distress, major depression and anxiety in adults with cancer. Canadian Partnership Against Cancer (Cancer Journey Action Group) and the Canadian Association of Psychosocial Oncology, 1–344.

62.

B. R. A. Kidney Care Committee (Ed.). (2015). Depression and anxiety: The role of kidney care clinics. Vancouver: BC Renal Agency.

63.

Abdel-Kader, K., Unruh, M. L., & Weisbord, S. D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4(6), 1057–1064. https://doi.org/10.2215/cjn.00430109.PubMedPubMedCentralCrossRef

64.

Cukor, D., Peterson, R. A., Cohen, S. D., & Kimmel, P. L. (2006). Depression in end-stage renal disease hemodialysis patients. Nature Clinical Practice Nephrology, 2(12), 678–687. https://doi.org/10.1038/ncpneph0359 PubMedCrossRef

65.

Greene, G. M. (2013). Description of a psychosocial assessment instrument and risk criteria to support social work recommendations for kidney transplant candidates. Social Work in Health Care, 52(4), 370–396. https://doi.org/10.1080/00981389.2013.764378.PubMedCrossRef

66.

Wright, P., Smith, A. B., Keding, A., & Velikova, G. (2011). The social difficulties inventory (SDI): Development of subscales and scoring guidance for staff. Psycho-Oncology, 20(1), 36–43. https://doi.org/10.1002/pon.1705.PubMedCrossRef

67.

Ashley, L., Velikova, G., Downing, A., Morris, E., & Wright, P. (2017). Health-related quality of life in cancer survivorship: Predictive power of the social difficulties inventory. Psychooncology, 26(11), 1994–1997. https://doi.org/10.1002/pon.4368.PubMedCrossRef

68.

Wright, E. P., Kiely, M., Johnston, C., Smith, A. B., Cull, A., & Selby, P. J. (2005). Development and evaluation of an instrument to assess social difficulties in routine oncology practice. Qual Life Res, 14(2), 373–386.PubMedCrossRef

69.

Kwok, M., Liao, B., Wong, D., Tang, E., Khalafi, F., Edwards, N., et al. (2017). Psychosocial distress and health related quality of life in kidney transplant recipients. Paper presented at the CST-CNTRP-SQT Joint Scientific Meeting Halifax, NS, Canada.

70.

Richardson, C., Belenko, D., Mucsi, E. C., Edwards, N., Wong, D., Novak, M., et al. (2017). Psychosocial distress in chronic kidney disease: Benefits of kidney transplantation. Paper presented at the American Transplant Congress, Chicago, IL, USA.

71.

Tavakol, M., & Dennick, R. (2011). Making sense of Cronbach’s alpha. International Journal of Medical Education, 2, 53–55. https://doi.org/10.5116/ijme.4dfb.8dfd.PubMedPubMedCentralCrossRef

72.

Bland, J. M., & Altman, D. G. (1997). Statistics notes: Cronbach’s alpha. BMJ, 314(7080), 572. https://doi.org/10.1136/bmj.314.7080.572 PubMedPubMedCentralCrossRef

73.

Weir, J. P. (2005). Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. Journal of Strength and Conditioning Research, 19(1), 231–240. https://doi.org/10.1519/15184.1.PubMedCrossRef

74.

Byrne, B. M. (1994). Structural equation modeling with EQS and EQS-windows: Basic concepts, applications, and programming. Thousand Oaks: Sage Publications, Inc.

75.

Browne, M. W., & Cudeck, R. (1992). Alternative ways of assessing model fit. Sociological Methods & Research, 21(2), 230–258. https://doi.org/10.1177/0049124192021002005.CrossRef

76.

Hinkle, D. E., Wiersma, W., & Jurs, S. G. (2003). Applied Statistics for the Behavioral Sciences (Vol. 663): Boston: Houghton Mifflin.

77.

Ruscio, J. (2008). A probability-based measure of effect size: Robustness to base rates and other factors. Psychological Methods, 13(1), 19–30. https://doi.org/10.1037/1082-989x.13.1.19.PubMedCrossRef

78.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd). Hillsdale: Erlbaum.

79.

Bear, R. A., & Stockie, S. (2014). Patient engagement and patient-centred care in the management of advanced chronic kidney disease and chronic kidney failure. Canadian Journal of Kidney Health and Disease, 1, 24. https://doi.org/10.1186/s40697-014-0024-7.PubMedPubMedCentralCrossRef

80.

Hemmelgarn, B. R., Pannu, N., Ahmed, S. B., Elliott, M. J., Tam-Tham, H., Lillie, E., et al. (2017). Determining the research priorities for patients with chronic kidney disease not on dialysis. Nephrology, Dialysis, Transplantation, 32(5), 847–854. https://doi.org/10.1093/ndt/gfw065.PubMedCrossRef

81.

Tong, A., Sainsbury, P., Carter, S. M., Hall, B., Harris, D. C., Walker, R. G., et al. (2008). Patients’ priorities for health research: Focus group study of patients with chronic kidney disease. Nephrology, Dialysis, Transplantation, 23(10), 3206–3214. https://doi.org/10.1093/ndt/gfn207.PubMedCrossRef

82.

Knight, S. R., Metcalfe, L., O’Donoghue, K., Ball, S. T., Beale, A., Beale, W., et al. (2016). Defining priorities for future research: Results of the UK kidney transplant priority setting partnership. PloS ONE, 11(10), e0162136. https://doi.org/10.1371/journal.pone.0162136.PubMedPubMedCentralCrossRef

83.

Quach, C. W., Langer, M. M., Chen, R. C., Thissen, D., Usinger, D. S., Emerson, M. A., et al. (2016). Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study. Quality of Life Research, 25(11), 2811–2823. https://doi.org/10.1007/s11136-016-1325-3.PubMedPubMedCentralCrossRef

84.

Peter, M. K., Wilco, H. M. E., & Klaas, S. (2013). Assessing individual change using short tests and questionnaires. Applied Psychological Measurement, 38(3), 201–216. https://doi.org/10.1177/0146621613510061.CrossRef

85.

Ziegler, M., Kemper, C. J., & Kruyen, P. (2014). Short scales—five misunderstandings and ways to overcome them. Journal of Individual Differences, 35(4), 185–189. https://doi.org/10.1027/1614-0001/a000148.CrossRef

86.

Heene, M., Bollmann, S., & Bühner, M. (2014). Much ado about nothing, or much to do about something? Journal of Individual Differences, 35(4), 245–249. https://doi.org/10.1027/1614-0001/a000146.CrossRef

87.

Broderick, J. E., DeWitt, E. M., Rothrock, N., Crane, P. K., & Forrest, C. B. (2013). Advances in patient-reported outcomes: The NIH PROMIS(®) Measures. EGEMS, 1(1), 1015. https://doi.org/10.13063/2327-9214.1015.PubMedPubMedCentralCrossRef

88.

Fukunishi, I., Hasegawa, A., Ohara, T., Aikawa, A., Hatanaka, A., Suzuki, J., et al. (1997). Kidney transplantation and liaison psychiatry, part I: Anxiety before, and the prevalence rate of psychiatric disorders before and after, transplantation. Psychiatry and Clinical Neurosciences, 51(5), 301–304. https://doi.org/10.1111/j.1440-1819.1997.tb03202.x.PubMedCrossRef

89.

Chandrasekaran, A., Anand, G., Sharma, L., Pesavanto, T., Hauenstein, M. L., Nguyen, M., et al. (2016). Role of in-hospital care quality in reducing anxiety and readmissions of kidney transplant recipients. Journal of Surgical Research, 205(1), 252–259.e251. https://doi.org/10.1016/j.jss.2016.05.032.PubMedCrossRef

90.

Parsaei Mehr, Z., Hami, M., & Moshtagh Eshgh, Z. (2011). Anxiety and depression: A comparison between living and cadaveric renal transplant recipients. International Journal of Organ Transplantation Medicine, 2(4), 178–183.PubMedPubMedCentral

91.

Karaminia, R., Tavallaii, S. A., Lorgard-Dezfuli-Nejad, M., Moghani Lankarani, M., Mirzaie, H., Einollahi, H., B., et al. (2007). Anxiety and depression: A comparison between renal transplant recipients and hemodialysis patients. Transplantation Proceedings, 39(4), 1082–1084. https://doi.org/10.1016/j.transproceed.2007.03.088.PubMedCrossRef

92.

Ferris, M. E., Miles, J. A., & Seamon, M. L. (2016). Adolescents and young adults with chronic or end-stage kidney disease. Blood Purification, 41(1–3), 205–210.PubMedCrossRef

93.

Paz, S. H., Spritzer, K. L., Morales, L. S., & Hays, R. D. (2013). Age-related differential item functioning for the Patient-Reported Outcomes Measurement Information System (PROMIS®) physical functioning items. Primary Health Care: Open Access, 3(131), 12086. https://doi.org/10.4172/2167-1079.1000131.CrossRef

94.

Jana, A. K., Sircar, D., Waikhom, R., Praharaj, S. K., Pandey, R., RayChaudhury, A., et al. (2014). Depression and anxiety as potential correlates of post-transplantation renal function and quality of life. Indian Journal of Nephrology, 24(5), 286–290. https://doi.org/10.4103/0971-4065.132996.PubMedPubMedCentralCrossRef

95.

Esposito, P., Furini, F., Rampino, T., Gregorini, M., Petrucci, L., Klersy, C., et al. (2017). Assessment of physical performance and quality of life in kidney-transplanted patients: A cross-sectional study. Clinical Kidney Journal, 10(1), 124–130. https://doi.org/10.1093/ckj/sfw102.PubMedCrossRef

Titel: Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients
verfasst von: Evan Tang
Oladapo Ekundayo
John Devin Peipert
Nathaniel Edwards
Aarushi Bansal
Candice Richardson
Susan J. Bartlett
Doris Howell
Madeline Li
David Cella
Marta Novak
Istvan Mucsi
Publikationsdatum: 22.11.2018
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 3/2019
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-018-2058-2

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Health-related quality of life among cancer survivors in rural China

Apathy and health-related quality of life in nursing home residents

Group singing improves depression and life quality in patients with stable COPD: a randomized community-based trial in China

Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer

Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user’s guide

Assessing the measurement invariance of the RCADS-25 questionnaire across gender and child–parent dyads in the presence of multilevel data